Literature DB >> 20127454

Classification of mental health disorders in the perinatal period: future directions for DSM-V and ICD-11.

Marie-Paule Austin1.   

Abstract

Mesh:

Year:  2010        PMID: 20127454     DOI: 10.1007/s00737-009-0110-5

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


× No keyword cloud information.
  5 in total

1.  Postpartum depressive symptoms across time and place: structural invariance of the Self-Reporting Questionnaire among women from the international, multi-site MAL-ED study.

Authors:  Laura L Pendergast; Rebecca J Scharf; Zeba A Rasmussen; Jessica C Seidman; Barbara A Schaefer; Erling Svensen; Fahmida Tofail; Beena Koshy; Margaret Kosek; Muneera A Rasheed; Reeba Roshan; Angelina Maphula; Rita Shrestha; Laura E Murray-Kolb
Journal:  J Affect Disord       Date:  2014-06-12       Impact factor: 4.839

2.  Are symptom features of depression during pregnancy, the postpartum period and outside the peripartum period distinct? Results from a nationally representative sample using item response theory (IRT).

Authors:  Nicolas Hoertel; Saioa López; Hugo Peyre; Melanie M Wall; Ana González-Pinto; Frédéric Limosin; Carlos Blanco
Journal:  Depress Anxiety       Date:  2014-11-25       Impact factor: 6.505

Review 3.  [Mental disorders in pregnancy and postpartum : Prevalence, course, and clinical diagnostics].

Authors:  C Kühner
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

4.  A cross-sectional study of the prevalence and factors associated with symptoms of perinatal depression and anxiety in Rwanda.

Authors:  Marie Providence Umuziga; Oluyinka Adejumo; Michaela Hynie
Journal:  BMC Pregnancy Childbirth       Date:  2020-01-31       Impact factor: 3.007

Review 5.  The Value of HPA Axis Hormones as Biomarkers for Screening and Early Diagnosis of Postpartum Depression: Updated Information About Methodology.

Authors:  Yujuan Chai; Qihang Li; Yang Wang; Enxiang Tao; Tetsuya Asakawa
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.